Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (23399)	7/21/1998 11:53:00 AM
From: bob zagorin	Read Replies (1) \| Respond to of 32384

even though it causes an overhang in the short term, it makes sense that Allergan sell its shares. With the collaboration ended, no one would want a major competitor to have that much influence as 10x the holding of CEO.

To: Mudcat who wrote (23399)	7/21/1998 12:01:00 PM
From: Robert L. Ray	Read Replies (1) \| Respond to of 32384

If your going to include Allergan on the insider holdings list then you need to include the other big pharma's/partners that also own a number of LGND shares. I saw a list of them the other day and the number of shares they held but I failed to bookmark it. They most definatly would break into the top ten list.